Welcome!

News Feed Item

Castlight Health Announces Second Quarter 2014 Results

Castlight Health®, Inc. (NYSE:CSLT), a pioneer of the Enterprise Healthcare Cloud, today announced results for its second quarter ended June 30, 2014.

“Demand for Castlight’s Enterprise Healthcare Cloud remains strong as large organizations are increasingly evaluating enterprise healthcare technology to gain control of their healthcare spending,” said Giovanni Colella, M.D., co-founder and Chief Executive Officer of Castlight Health. “We ended the second quarter with 130 customers and expanded our Fortune 500 customer list by more than 20 percent. New large customers included Google, Kellogg Company, Texas Instruments and Sprint Corporation, among others. Further, we continue to execute well. We launched 13 additional customers during the second quarter, including CalPERS, and implemented Castlight Pharmacy and Castlight Rewards for 12 existing customers.”

Colella continued, “We continue to launch new products and lead the way with technologies that enable innovative benefit designs for our customers. We were pleased to announce the upcoming launch of Castlight Dental, which is the newest significant expansion of our Castlight Care Solution Center alongside Castlight Medical and Castlight Pharmacy.”

Financial Performance for the Three Months Ended June 30, 2014

  • Total revenue for the second quarter of 2014 was $10.5 million, an increase of 353% from the second quarter of 2013. Subscription revenue was $9.6 million, an increase of 359% on a year-over-year basis. Professional services revenue was $1.0 million, an increase of 304% compared with the same period last year.
  • Gross margin for the second quarter of 2014 was 29.6%, compared to a gross loss of 64.9% in the second quarter of 2013. Non-GAAP gross margin for the second quarter of 2014 was 32.6% compared to a gross loss of 63.9% in the second quarter of 2013.
  • Operating loss for the second quarter of 2014 was $21.8 million, compared to an operating loss of $14.2 million during the second quarter of 2013. Non-GAAP operating loss for the second quarter of 2014 was $18.8 million, compared to a non-GAAP operating loss of $13.7 million during the second quarter of 2013.
  • Net loss per basic and diluted share was ($0.24) in the second quarter of 2014, compared to a loss of ($1.47) per share in the second quarter of 2013. The non-GAAP net loss per share for the second quarter of 2014 was ($0.21), compared to a loss of ($1.43) per share in the second quarter of 2013. For both GAAP and non-GAAP purposes, the weighted average basic and diluted share count for the second quarter of 2014 was 89.5 million compared to 9.6 million in the second quarter of 2013.
  • Total cash, cash equivalents and marketable securities were $217.9 million at the end of the second quarter of 2014, compared to $239.7 million at the end of last quarter. Cash used in operations for the second quarter of 2014 was $19.6 million, compared to $16.1 million used in operations last quarter.

A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures”.

Business Outlook

Q3 2014 Guidance: Revenue for the company’s third fiscal quarter is expected to be in the range of $11.3 million to $11.6 million, an increase of 214% to 222% year-over-year. Non-GAAP operating loss is expected to be in the range of ($18.7) million to ($19.0) million. Non-GAAP basic and diluted loss per share is expected to be approximately ($0.21) based on 90.0 million weighted average basic and diluted common shares outstanding.

Full Year 2014 Guidance: Revenue for the company’s full year 2014 is expected to be in the range of $42.6 million to $43.2 million, an increase of 228% to 232% year-over- year. Non-GAAP operating loss is expected to be in the range of ($75.0) million to ($76.0) million. Non-GAAP basic and diluted loss per share is expected to be in the range of ($1.00) to ($1.01) based on 75.0 million weighted average basic and diluted common shares outstanding.

For both the third quarter and the full year 2014, non-GAAP estimates exclude the effects of stock-based compensation expense and warrant expense.

Leadership Updates

Castlight Health announced today that Randy Womack, chief operating officer, will step down September 30, 2014 after nearly four years of service with the company. Mr. Womack’s responsibilities will be assumed by other members of Castlight’s management team after a seamless transition process is completed.

Additionally, Concur CEO Steve Singh has joined Castlight’s Board of Directors, effective immediately. Concurrently, directors Bob Kocher, M.D., partner at Venrock, and Christopher P. Michel, managing director at Nautilus Ventures, departed the Board. Dr. Kocher will remain as an advisor to the company, and Bryan Roberts, co-founder of Castlight and general partner at Venrock, remains Castlight’s Chairman of the Board. These changes follow the April addition of Ed Park, executive vice president and chief operating officer of athenahealth to the Board of Directors.

“We would like to thank Randy for his efforts to help make Castlight such a great company and achieve such strong momentum as a business. Randy has decided to leave the company with the success of his third IPO to pursue his passion for startups. We wish him every success in his future endeavors,” said Colella. “Moving forward, Castlight has an incredibly strong group of experienced, proven leaders. I look forward to working with them to continue to capture growth and realize innovation opportunities.”

Quarterly Conference Call

Castlight Health will host a conference call to discuss its second quarter results today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations website at http://ir.castlighthealth.com. In addition, an archive of the audiocast can be accessed through the same link. Participants who choose to call in to the conference call can do so by dialing 1-201-689-8562. A replay will be available at 1-858-384-5517, passcode 13586458, until midnight (Eastern Time) August 5, 2014.

About Castlight Health

Castlight Health, Inc. (NYSE: CSLT) believes great healthcare builds great business. The Castlight Enterprise Healthcare Cloud enables employers to deliver cost-effective benefits, provides medical professionals and health plans a merit-based market to showcase their services, and – most importantly – empowers employees to make informed choices with a clear understanding of costs and likely outcomes. For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health.

Non-GAAP Financial Measures

To supplement Castlight Health’s financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross margin (loss), non-GAAP operating expense, non-GAAP operating loss and non-GAAP net loss per share. These non-GAAP financial measures differ from GAAP financial measures in that they exclude stock-based compensation, expense for a warrant issued to a third-party service provider and the associated tax impact of these items, where applicable.

We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company’s core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company’s historical financial performance.

We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the third quarter and full fiscal year of 2014 to comparable GAAP operating loss and net loss per share guidance because we do not provide guidance for stock-based compensation expense and warrant expense, which are reconciling items between GAAP and non-GAAP operating loss. The factors that may impact our future stock-based compensation expense and warrant expense are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort.

These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP. Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company’s financial information in its entirety and not rely on a single financial measure.

Safe Harbor For Forward-Looking Statements

This press release contains forward-looking statements about Castlight Health’s expectations, plans, intentions, and strategies, including, but not limited to, statements regarding Castlight Health’s third quarter and full year projections, our expectations for future performance of our business, market growth and business conditions, future innovation by the company and future developments with respect to the digital healthcare industry. Statements including words such as “anticipate,” “believe,” “estimate,” “will,” “continue,” “expect,” or “future,” and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties include those described in Castlight Health’s documents filed with or furnished to the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Castlight Health as of the date hereof. Castlight Health assumes no obligation to update these forward-looking statements.

Copyright 2014 Castlight Health, Inc. Castlight Health, Castlight, Castlight Medical, Castlight Pharmacy, Castlight Dental, Castlight Care Solution Center are trademarks and/or registered trademarks of Castlight Health Inc. in the United States and other countries. Other company and product names may be trademarks of the respective companies with which they are associated.

 
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
     
 
As of
June 30, December 31,
2014 2013
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 35,268 $ 25,154
Marketable securities 124,560 42,017
Accounts receivable, net 10,392 5,065
Deferred commissions 2,946 3,648
Prepaid expenses and other current assets   3,010   1,583  
Total current assets 176,176 77,467
 
Property and equipment, net 3,164 2,631
Marketable securities, noncurrent 58,095 -

Restricted cash, noncurrent

- 101
Deferred commissions, noncurrent 1,648 1,821
Other assets   380   1,497  
Total assets $ 239,463 $ 83,517  
 
Liabilities, convertible preferred stock and stockholders' equity (deficit)
 
Current liabilities:
Accounts payable $ 2,928 $ 2,536
Accrued expenses and other current liabilities 3,937 4,998
Accrued compensation 6,984 8,064
Deferred revenue   13,970   6,925  
Total current liabilities 27,819 22,523
 
Deferred revenue, noncurrent 5,780 4,548
Other liabilities, noncurrent   317   373  
Total liabilities 33,916 27,444
Commitments and contingencies
Convertible preferred stock - 180,423
Stockholders' equity (deficit)   205,547   (124,350 )
Total liabilities, convertible preferred stock and stockholders' equity (deficit) $ 239,463 $ 83,517  
 
         
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(unaudited)
 
 
Three Months Ended June 30, Six Months Ended June 30,
  2014     2013     2014     2013  
Revenue:
Subscription $ 9,576 $ 2,088 $ 17,039 $ 3,827
Professional services   957     237     1,870     405  
Total revenue   10,533     2,325     18,909     4,232  
Cost of revenue:
Cost of subscription (1) 2,915 1,460 5,627 2,664
Cost of professional services (1)   4,502     2,373     8,373     4,426  
Total cost of revenue   7,417     3,833     14,000     7,090  
Gross profit (loss)   3,116     (1,508 )   4,909     (2,858 )
Operating expenses:
Sales and marketing (1) 14,947 7,108 31,507 12,873
Research and development (1) 5,476 3,616 11,003 6,524
General and administrative (1)   4,519     1,981     8,529     3,441  
Total operating expenses   24,942     12,705     51,039     22,838  
Operating loss (21,826 ) (14,213 ) (46,130 ) (25,696 )
Other income, net   50     40     73     90  
Net loss $ (21,776 ) $ (14,173 ) $ (46,057 ) $ (25,606 )
 
Net loss per share, basic and diluted $ (0.24 ) $ (1.47 ) $ (0.86 ) $ (2.71 )
 
Weighted-average shares used in basic and diluted net loss per share   89,520     9,619     53,284     9,438  
 
 
(1)Includes stock-based compensation expense as follows:
 
Three Months Ended June 30, Six Months Ended June 30,
  2014     2013     2014     2013  
 
Cost of revenue:
Cost of subscription $ 35 $ - $ 39 $ 1
Cost of professional services 280 23 420 52
Sales and marketing 1,152 225 2,326 408
Research and development 493 61 914 110
General and administrative 980 156 1,794 272
 
         
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(unaudited)
 
 
Three Months Ended June 30, Six Months Ended June 30,
2014 2013 2014 2013
Operating activities:
Net loss $ (21,776 ) $ (14,173 ) $ (46,057 ) $ (25,606 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation 322 113 604 213
Stock-based compensation 2,940 465 5,493 843
Amortization of deferred commission 868 196 2,244 325
Accretion and amortization of marketable securities 373 193 497 421
Expense related to issuance of warrant 70 - 2,499 -
Changes in operating assets and liabilities:
Accounts receivable (4,077 ) (1,412 ) (5,327 ) (1,387 )
Deferred commissions (1,087 ) (700 ) (1,369 ) (1,267 )
Prepaid expenses and other assets (596 ) (435 ) (1,677 ) (535 )
Accounts payable (375 ) 849 384 279
Accrued expenses and other liabilities 2,173 2,406 (1,203 ) 1,109
Deferred revenue   1,591     2,493     8,277     3,446  
Net cash used in operating activities   (19,574 )   (10,005 )   (35,635 )   (22,159 )
 
Investing activities
Decrease restricted cash, net 101 - 101 -
Purchase of property and equipment (311 ) (408 ) (967 ) (1,118 )
Purchase of marketable securities (126,442 ) (8,382 ) (162,175 ) (16,480 )
Sales of marketable securities - - 13,000 5,000
Maturities of marketable securities   3,000     39,075     8,000     44,075  
Net cash (used in) provided by investing activities   (123,652 )   30,285     (142,041 )   31,477  
 
Financing activities
Proceeds from the exercise of stock options 106 154 1,628 200
Payments of deferred financing costs (1,679 ) - (3,781 ) -

Net proceeds from initial public offering

  -     -     189,943     -  
Net cash (used in) provided by financing activities   (1,573 )   154     187,790     200  
 
Net increase (decrease) in cash and cash equivalents (144,799 ) 20,434 10,114 9,518
Cash and cash equivalents at beginning of the period   180,067     31,618     25,154     42,534  
Cash and cash equivalents at end of the period $ 35,268   $ 52,052   $ 35,268   $ 52,052  
 
   
CASTLIGHT HEALTH, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(unaudited)
 
Three Months Ended Six Months Ended
June 30, March 31, June 30, June 30, June 30,
2014 2014 2013 2014 2013
Gross profit (loss):

GAAP gross profit subscription

$ 6,661 $ 4,751 $ 628 $ 11,412 $ 1,163
GAAP gross margin subscription 69.6 % 63.7 % 30.1 % 67.0 % 30.4 %
Stock-based compensation expense included in cost of revenue subscription   35     4     -     39     1  
Non-GAAP gross profit subscription $ 6,696   $ 4,755   $ 628   $ 11,451   $ 1,164  
Non-GAAP gross margin subscription 69.9 % 63.7 % 30.1 % 67.2 % 30.4 %
 
GAAP gross loss professional services $ (3,545 ) $ (2,958 ) $ (2,136 ) $ (6,503 ) $ (4,021 )
GAAP gross loss percentage professional services (370 ) % (324 ) % (901 ) % (348 ) % (993 ) %
Stock-based compensation expense included in cost of revenue professional services   280     140     23     420     52  
Non-GAAP gross loss professional services $ (3,265 ) $ (2,818 ) $ (2,113 ) $ (6,083 ) $ (3,969 )
Non-GAAP gross loss percentage professional services (341 ) % (309 ) % (892 ) % (325 ) % (980 ) %
 
GAAP gross profit (loss) $ 3,116 $ 1,793 $ (1,508 ) $ 4,909 $ (2,858 )
GAAP gross margin (loss percentage) 29.6 % 21.4 % (64.9 ) % 26.0 % (67.5 ) %
Impact of non-GAAP adjustments   315     144     23     459     53  
Non-GAAP gross profit (loss) $ 3,431   $ 1,937   $ (1,485 ) $ 5,368   $ (2,805 )
Non-GAAP gross margin (loss percentage) 32.6 % 23.1 % (63.9 ) % 28.4 % (66.3 ) %
 
Operating expense:
GAAP sales and marketing $ 14,947 $ 16,560 $ 7,108 $ 31,507 $ 12,873
Expense related to warrant (70 ) (2,429 ) - (2,499 ) -
Stock-based compensation expense included in sales and marketing   (1,152 )   (1,174 )   (225 )   (2,326 )   (408 )
Non-GAAP sales and marketing $ 13,725   $ 12,957   $ 6,883   $ 26,682   $ 12,465  
 
GAAP research and development $ 5,476 $ 5,527 $ 3,616 $ 11,003 $ 6,524
Stock-based compensation expense included in research and development   (493 )   (421 )   (61 )   (914 )   (110 )
Non-GAAP research and development $ 4,983   $ 5,106   $ 3,555   $ 10,089   $ 6,414  
 
GAAP general and administrative $ 4,519 $ 4,010 $ 1,981 $ 8,529 $ 3,441
Stock-based compensation expense included in general and administrative   (980 )   (814 )   (156 )   (1,794 )   (272 )
Non-GAAP general and administrative $ 3,539   $ 3,196   $ 1,825   $ 6,735   $ 3,169  
 
GAAP operating expenses $ 24,942 $ 26,097 $ 12,705 $ 51,039 $ 22,838
Impact of non-GAAP adjustments   (2,695 )   (4,838 )   (442 )   (7,533 )   (790 )
Non-GAAP operating expenses $ 22,247   $ 21,259   $ 12,263   $ 43,506   $ 22,048  
 
Operating loss:
GAAP operating loss $ (21,826 ) $ (24,304 ) $ (14,213 ) $ (46,130 ) $ (25,696 )
Impact of non-GAAP adjustments   3,010     4,982     465     7,992     843  
Non-GAAP operating loss $ (18,816 ) $ (19,322 ) $ (13,748 ) $ (38,138 ) $ (24,853 )
 
Net loss and net loss per share:
GAAP net loss $ (21,776 ) $ (24,281 ) $ (14,173 ) $ (46,057 ) $ (25,606 )
Total pre-tax impact of non-GAAP adjustments 3,010 4,982 465 7,992 843
Income tax impact of non-GAAP adjustments   -     -     -     -     -  
Non-GAAP net loss $ (18,766 ) $ (19,299 ) $ (13,708 ) $ (38,065 ) $ (24,763 )
 
Basic and Diluted net loss per share
GAAP $ (0.24 ) $ (0.90 ) $ (1.47 ) $ (0.86 ) $ (2.71 )
Non-GAAP $ (0.21 ) $ (0.72 ) $ (1.43 ) $ (0.71 ) $ (2.62 )
 
Shares used in basic and diluted net loss per share computation   89,520     26,970     9,619     53,284     9,438  
 
Free Cash Flow
 
GAAP net cash flow used in operating activities $ (19,574 ) $ (16,061 ) $ (10,005 ) $ (35,635 ) $ (22,159 )
Purchase of property and equipment   (311 )   (656 )   (408 )   (967 )   (1,118 )
Free cash flow $ (19,885 ) $ (16,717 ) $ (10,413 ) $ (36,602 ) $ (23,277 )
 

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities – ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups. As a result, many firms employ new business models that place enormous impor...
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
As popularity of the smart home is growing and continues to go mainstream, technological factors play a greater role. The IoT protocol houses the interoperability battery consumption, security, and configuration of a smart home device, and it can be difficult for companies to choose the right kind for their product. For both DIY and professionally installed smart homes, developers need to consider each of these elements for their product to be successful in the market and current smart homes.
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, will go over the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, applicatio...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, will lead you through the exciting evolution of the cloud. He'll look at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering ...
As hybrid cloud becomes the de-facto standard mode of operation for most enterprises, new challenges arise on how to efficiently and economically share data across environments. In his session at 21st Cloud Expo, Dr. Allon Cohen, VP of Product at Elastifile, will explore new techniques and best practices that help enterprise IT benefit from the advantages of hybrid cloud environments by enabling data availability for both legacy enterprise and cloud-native mission critical applications. By rev...
SYS-CON Events announced today that Dasher Technologies will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Dasher Technologies, Inc. ® is a premier IT solution provider that delivers expert technical resources along with trusted account executives to architect and deliver complete IT solutions and services to help our clients execute their goals, plans and objectives. Since 1999, we'v...
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp emp...
SYS-CON Events announced today that TidalScale, a leading provider of systems and services, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale has been involved in shaping the computing landscape. They've designed, developed and deployed some of the most important and successful systems and services in the history of the computing industry - internet, Ethernet, operating s...
SYS-CON Events announced today that Massive Networks, that helps your business operate seamlessly with fast, reliable, and secure internet and network solutions, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. As a premier telecommunications provider, Massive Networks is headquartered out of Louisville, Colorado. With years of experience under their belt, their team of...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.